New Guidelines for Severe Asthma Provide Updated Treatment, Definition of … – Science Daily (press release)

New Guidelines for Severe Asthma Provide Updated Treatment, Definition of
Science Daily (press release)
Although severe asthma is estimated to account for less than 10% of all asthmatics, these patients have the greatest burden and require a disproportionate amount of healthcare costs to be spent on treating their condition, which is harder to control.

View full post on asthma – Google News

A treatment for obesity-associated asthma – Medical Xpress

A treatment for obesity-associated asthma
Medical Xpress
(Medical Xpress)—Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond poorly to standard asthma 
Obesity May Cause Asthma by Altering the Immune SystemSacramento Bee

all 4 news articles »

View full post on asthma – Google News

Dynavax starts Phase I trial of asthma treatment – San Francisco Business Times (blog)

Dynavax starts Phase I trial of asthma treatment
San Francisco Business Times (blog)
The Berkeley company (NASDAQ: DVAX) will enroll up to 45 people in this Phase I trial of AZD1419, an inhaled TLR9 agonist. These pioneering patients will all be healthy, and they'll get either the drug in ascending doses or a placebo. If all goes well, 
DYNAVAX TECHNOLOGIES CORPORATION : Dynavax Initiates First Human 4-traders (press release)
Dynavax Initiates First Human Trial in Asthma ProgramMENAFN.COM

all 3 news articles »

View full post on asthma – Google News

AsthmaMist: The 100% Natural Asthma Treatment Homeopathic Spray Now … – SBWire (press release)

AsthmaMist: The 100% Natural Asthma Treatment Homeopathic Spray Now
SBWire (press release)
Life becomes extremely miserable from the time the deadly disease of asthma attacks a person as they cannot be normal anymore, or involve in extrinsic activities but just take plenty of medications and rest all the day. It can also be very tiring and

View full post on asthma – Google News

Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis

Condition:   Colitis, Ulcerative
Interventions:   Biological: Trichuris suis ova (TSO);   Biological: Placebo
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID);   Coronado Biosciences, Inc.
Not yet recruiting – verified September 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Many People in US Misdiagnosed with Asthma, Receive Unnecessary Treatment – Nature World News


Nature World News

Many People in US Misdiagnosed with Asthma, Receive Unnecessary Treatment
Nature World News
"It's very logical for general practitioners to assume most breathing problems are asthma, especially in children," said Tod Olin, MD, a pediatric pulmonologist at National Jewish Health. "But there are a lot of breathing problems out there, and for
Asthma patients may be misdiagnosedDoctor Tipster

all 3 news articles »

View full post on asthma – Google News

Yourwellness Magazine Considers Acupuncture for Asthma Treatment – PR Web (press release)

Yourwellness Magazine Considers Acupuncture for Asthma Treatment
PR Web (press release)
As a promising asthma monitoring device is yet to gain FDA clearance, Yourwellness Magazine explored other asthma treatment options, considering the use of acupuncture for relieving asthma symptoms. Share on Twitter Share on Facebook Share on 

and more »

View full post on asthma – Google News

Relvar Ellipta Approved in Japan for Treatment of Asthma – Benzinga

Relvar Ellipta Approved in Japan for Treatment of Asthma
Benzinga
GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma (in cases where 
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma NASDAQ
Double asthma approval in Japan lifts SkyePharmaPMLiVE
Asthma drugs head Japan approvalsPharmaTimes
Stock Market Wire –Zacks.com –Reuters
all 19 news articles »

View full post on asthma – Google News

AsthmaMist: The Most Powerful Asthma Treatment Product Now Offers 2 Months … – SBWire (press release)

AsthmaMist: The Most Powerful Asthma Treatment Product Now Offers 2 Months
SBWire (press release)
Life becomes extremely miserable from the time the deadly disease of asthma attacks a person as they cannot be normal anymore, or involve in extrinsic activities but just take plenty of medications and rest all the day. It can also be very tiring and

View full post on asthma – Google News